Facilitating the development of cross-platform mHealth applications for chronic supportive care and a case study.

Applications Cross-platform Mobile computing Mobile devices Mobile health Smartphones

Journal

Journal of biomedical informatics
ISSN: 1532-0480
Titre abrégé: J Biomed Inform
Pays: United States
ID NLM: 100970413

Informations de publication

Date de publication:
05 2020
Historique:
received: 18 09 2019
revised: 30 03 2020
accepted: 01 04 2020
pubmed: 11 4 2020
medline: 29 7 2021
entrez: 11 4 2020
Statut: ppublish

Résumé

Mobile health (mHealth) apps have received increasing attention, due to their abilities to support patients who suffer from various conditions. mHealth apps may be especially helpful for patients with chronic diseases, by providing pertinent information, tracking symptoms, and inspiring adherence to medication regimens. To achieve these objectives, researchers need to prototype mHealth apps with dedicated software architectures. In this paper, a cloud-based mHealth application development concept is presented for chronic patient supportive care apps. The concept integrates existing software platforms and services for simplified app development that can be reused for other target applications. This developmental method also facilitates app portability, through the use of common components found across multiple mobile platforms, and scalability, through the loose coupling of services. The results are demonstrated by the development of native Android and cross-platform web apps, in a case study that presents an mHealth solution for endocrine hormone therapy (EHT). A performance analysis methodology, an app usability evaluation, based on focus group responses, and alpha and pre-beta testing results are provided.

Identifiants

pubmed: 32275956
pii: S1532-0464(20)30048-4
doi: 10.1016/j.jbi.2020.103420
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103420

Subventions

Organisme : NCI NIH HHS
ID : P30 CA054174
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA153511
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Devasena Inupakutika (D)

Department of Electrical and Computer Engineering, The University of Texas at San Antonio, TX, 78249, USA. Electronic address: devasena.inupakutika@my.utsa.edu.

Sahak Kaghyan (S)

Department of Electrical and Computer Engineering, The University of Texas at San Antonio, TX, 78249, USA. Electronic address: sahak.kaghyan@gmail.com.

David Akopian (D)

Department of Electrical and Computer Engineering, The University of Texas at San Antonio, TX, 78249, USA. Electronic address: david.akopian@utsa.edu.

Patricia Chalela (P)

Institute for Health Promotion Research (IHPR), University of Texas Health San Antonio, San Antonio, TX, 78229, USA. Electronic address: chalela@uthscsa.edu.

Amelie G Ramirez (AG)

Institute for Health Promotion Research (IHPR), University of Texas Health San Antonio, San Antonio, TX, 78229, USA. Electronic address: ramirezag@uthscsa.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH